If you spend any time at all in the world of infection control and prevention, you've run across the NHSN, or National Healthcare Safety Network. Those of us who are not directly involved with infection control, however, may lack a full understanding of what the NHSN truly is. Today's post is for those of us who work on the periphery of infection control efforts: An introduction to the NHSN.
We've covered Candida auris in this blog before. Not only has it been one of the pathogens of concern cited by the Centers for Disease Control and Prevention, this fungus also infected record numbers of inpatients during the COVID-19 pandemic. This disease-causing pathogen has hit headlines once again, this time brining attention to troubling increases in rates and resistance. What can hospitals - and patients - do to avoid this dangerous hospital-associated infection?
In our last post, we explored how adopting a new product can result in some heavy lifting. Not only does product adoption require financial investment, it requires significant investment of time and resources even before the decision is made. Even after the new product is in place, the heavy lifting can continue, especially if the intended users are resistant to change. In today's post, we'll look at the obstacles to adopting new products, even if they are proven to improve patient outcomes or save money. Even if they are considered standard of care.
With World Cancer Day this Saturday, we dedicate this post to those patients facing a cancer diagnosis. As with any serious disease, the many types of cancer put a great deal of stress on the body and can make a person more susceptible to infection. Unique to cancer, however, are the infection risks due to the disease's treatment. Today we will explore how cancer and infection intersect in this special population.
The medical chart is set to become a thing of the past. Those thick folders containing your medical history are steadily being replaced by electronic health records, or EHR. The Veteran's Administration initiated the first large-scale implementation of these computerized files in the 1970s, but the concept was slow to catch on in general practice until the advent of a combination of powerful and affordable hardware, fast and secure internet, and reliable and seemingly endless cloud storage capabilities. Since then, EHR systems have been shown to make physician visits faster, help coordinate care between multiple offices, and improve health outcomes. Can EHR bring the same success to the fight against hospital acquired infections?
Many healthcare concerns will follow us into the new year, some we have carried for decades and some that have become more threatening thanks to the COVID pandemic. Among all the many lists of top concerns, three remain consistent: Staffing shortages, capacity, and healthcare-associated infections. In today's post, we will reveal how reducing healthcare associated infections (HAIs) directly improves patient outcomes, but can can positively impact staffing and capacity as well.
In our previous posts about the Case-Mix Index (CMI), we explored what it conveys and how it is calculated. Today we will discuss who looks at that the CMI and how they use it, including both clinical and financial entities.
Last week, we looked at Diagnosis-Related Groups and how they receive codes based on cost and complexity. These numbers play a key role in the Case-Mix Index, and today we will look at how those MS-DRGs form the basis of the CMI.
The Case-Mix Index (CMI) has been defined in many ways. One definition might read "a relative value assigned to a diagnostic-related group." Another may be "a rough estimate of how sick a hospital's patients are." Yet another could be "an indicator of how much reimbursement is expected by the hospital." All these definitions point to one fact: The CMI is a measure used by a variety of healthcare personnel in a variety of ways. This week we will begin our exploration of this multi-faceted number.
Among all tracked hospital-associated infections, the one that seems to have the lowest rates are surgical site infections. While this relative strength varies by region, the overall low rate of surgical site infections is due in part to so many of the opportunities for infection being eliminated by interventions. However, surgical site infections still occur and data seems to point at the contamination of the patient environment, including surfaces, playing a significant role. In today's post, we will look at all the opportunities for infection after a surgical procedure, and highlight which vulnerabilities still remain.
